We are live on ! Find out more
CEMI

Chembio diagnostics, Inc.

Delisted

CEMI was delisted on the 27th of April, 2023.

39 hedge funds and large institutions have $33M invested in Chembio diagnostics, Inc. in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 9

13% less funds holding

Funds holding: 4539 (-6)

27% less capital invested

Capital invested by funds: $45.2M → $33M (-$12.1M)

60% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 10

Holders
39
Holders Change
-6
Holders Change %
-13.33%
% of All Funds
0.77%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
17
Reduced
9
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$5.65M
RA
2
Royce & Associates
New York
$4.52M +$1.83M +375,874 +61%
SAM
3
Silvercrest Asset Management
New York
$3.11M -$142K -29,067 -4%
Vanguard Group
4
Vanguard Group
Pennsylvania
$3.09M
SBH
5
Segall Bryant & Hamill
Illinois
$2.7M +$187K +38,309 +7%
AIP
6
ARS Investment Partners
New York
$1.52M -$617K -126,615 -28%
GS
7
Gagnon Securities
New York
$1.47M -$517 -106 -0%
ISL
8
Ingalls & Snyder LLC
New York
$1.41M +$29.2K +6,000 +2%
GA
9
Gagnon Advisors
New York
$1.14M
BlackRock
10
BlackRock
New York
$974K +$120K +24,711 +13%
RC
11
Roubaix Capital
Colorado
$889K -$333K -68,315 -26%
PCM
12
Perkins Capital Management
Minnesota
$780K -$108K -22,200 -11%
PM
13
Penbrook Management
New York
$746K +$193K +39,690 +32%
EIM
14
Essex Investment Management
Massachusetts
$663K +$33.3K +6,828 +5%
BFM
15
Boothbay Fund Management
New York
$558K +$44.9K +9,211 +8%
Ameriprise
16
Ameriprise
Minnesota
$556K +$33.1K +6,800 +6%
Wells Fargo
17
Wells Fargo
California
$532K -$1.02M -209,372 -64%
CCA
18
Conestoga Capital Advisors
Pennsylvania
$529K +$424K +87,075 +300%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$495K
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$306K +$84.6K +17,354 +35%
Morgan Stanley
21
Morgan Stanley
New York
$224K +$21.4K +4,400 +10%
Northern Trust
22
Northern Trust
Illinois
$201K -$408K -83,647 -65%
LPL Financial
23
LPL Financial
California
$193K +$18K +3,700 +10%
HighTower Advisors
24
HighTower Advisors
Illinois
$155K +$92.6K +19,000 +128%
UBS Group
25
UBS Group
Switzerland
$122K -$385 -79 -0.3%

CEMI Hedge Fund Activity: Q4 2019 in Review

39 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q4 2019, worth a combined $33M — down 27% from $45.2M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of CEMI and 4 opened new positions — a net loss of 6 holders — while 9 trimmed existing stakes and 17 added.

The largest buyer was Royce & Associates, adding an estimated $1.83M. The largest seller was Wells Fargo, cutting an estimated $1.02M.

  • 39 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q4 2019, down from 45 in Q3 2019.
  • Funds reported $33M of Chembio diagnostics, Inc. stock for Q4 2019, down 27% quarter-over-quarter.
  • 4 funds opened new Chembio diagnostics, Inc. positions in Q4 2019 and 10 closed out, a net change of -6 holders.
  • The largest Chembio diagnostics, Inc. buyer in Q4 2019 was Royce & Associates, an estimated $1.83M added.
  • The largest Chembio diagnostics, Inc. seller in Q4 2019 was Wells Fargo, an estimated $1.02M sold.

Based on aggregated 13F filings for Q4 2019.